Approved for diagnostic, testing for pupils, and to control bleeding during surgery, or prevent rapid loss of sub-conjunctival injections into systemic circulation (0.01% & 0.1%)
Approved as chelating agent, aid to calcified corneal plaque removal
RNOH:
Non-formulary
UCLH:
Non-formulary
WH:
Non-formulary
FluorEscein injection (Ocular dye for fluoroscopic angiography)
Restricted
Provider notes
NMUH:
20% available
RFL:
Approve for ophthalmic angiography, e.g. examination of fundus and iris vasculature, sclera and episclera (10% & 20% available)
RNOH:
Non-formulary
UCLH:
WH:
Non-formulary
Glycerol eye drops (Ophthalmic)
Restricted
Provider notes
NMUH:
Non-formulary
RFL:
Approved for clearing corneal oedema (50% drops available)
RNOH:
Non-formulary
UCLH:
WH:
This is unlicensed and restricted to Ophthalmology
Mydricaine (Ophthalmic)
Unlicensed
Provider notes
NMUH:
For rapid mydriasis and prevention of synechiae in uveitis.
Mydricaine No.1 and No.2 Injection, available from ‘special-order’ manufacturers or specialist importing companies
RFL:
Non-formulary
RNOH:
Non-formulary
UCLH:
WH:
MYDRICAINE NO. 2 This is an unlicensed special and restricted to Ophthalmology.
MYDRICAINE NO.1 This is an unlicensed special and restricted to Ophthalmology.
....
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Homecare
Traffic Light Status Information
Status
Description
Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.
Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.
Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.
Medicines which should normally be prescribed by specialists only (hospital only).
For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.
Medicines not recommended for routine use in primary or secondary care.
Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.
Restricted
Unlicensed
